1. Home
  2. ITOS vs MVIS Comparison

ITOS vs MVIS Comparison

Compare ITOS & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • MVIS
  • Stock Information
  • Founded
  • ITOS 2011
  • MVIS 1993
  • Country
  • ITOS United States
  • MVIS United States
  • Employees
  • ITOS N/A
  • MVIS N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • MVIS Industrial Machinery/Components
  • Sector
  • ITOS Health Care
  • MVIS Technology
  • Exchange
  • ITOS Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • ITOS 270.7M
  • MVIS 308.8M
  • IPO Year
  • ITOS 2020
  • MVIS 1996
  • Fundamental
  • Price
  • ITOS $7.19
  • MVIS $1.13
  • Analyst Decision
  • ITOS Strong Buy
  • MVIS Buy
  • Analyst Count
  • ITOS 3
  • MVIS 4
  • Target Price
  • ITOS $26.00
  • MVIS $2.67
  • AVG Volume (30 Days)
  • ITOS 334.2K
  • MVIS 8.9M
  • Earning Date
  • ITOS 03-05-2025
  • MVIS 05-08-2025
  • Dividend Yield
  • ITOS N/A
  • MVIS N/A
  • EPS Growth
  • ITOS N/A
  • MVIS N/A
  • EPS
  • ITOS N/A
  • MVIS N/A
  • Revenue
  • ITOS $35,000,000.00
  • MVIS $8,147,000.00
  • Revenue This Year
  • ITOS N/A
  • MVIS N/A
  • Revenue Next Year
  • ITOS $121.70
  • MVIS $330.45
  • P/E Ratio
  • ITOS N/A
  • MVIS N/A
  • Revenue Growth
  • ITOS 177.89
  • MVIS 277.53
  • 52 Week Low
  • ITOS $6.67
  • MVIS $0.80
  • 52 Week High
  • ITOS $18.75
  • MVIS $2.31
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 48.18
  • MVIS 42.54
  • Support Level
  • ITOS $6.73
  • MVIS $0.99
  • Resistance Level
  • ITOS $7.32
  • MVIS $1.48
  • Average True Range (ATR)
  • ITOS 0.38
  • MVIS 0.15
  • MACD
  • ITOS 0.03
  • MVIS -0.03
  • Stochastic Oscillator
  • ITOS 53.06
  • MVIS 23.73

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: